Serum concentrations of endostatin in patients with vulvar cancer [2] (multiple letters)

Gynecologic Oncology

Volumn 74, Issue 1, 1999, Pages 151-152

  Hefler, L ^a   Tempfer, C ^a   Kainz, C ^a   Obermair, A ^a   Barb, M D ^a   Kasper, K ^a   Sutton, G P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN;

ANGIOGENESIS; BLOOD LEVEL; CELL PROLIFERATION; DIAGNOSTIC VALUE; HUMAN; LETTER; PRIORITY JOURNAL; TUMOR GROWTH; VULVA CARCINOMA; WOUND HEALING;

EID: 0032798506     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5496     Document Type: Editorial

References (6)

1. J Folkman Angiogenesis in cancer, vascular, rheumatoid, and other disease Nature Med 1 1995 27 31
2. EJ Battegay Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects J Mol Med 73 1995 333 346
3. MS O'Reilly T Boehm Y Shing N Fukai G Vasios WS Lane E Flynn JR Birkhead BR Olsen J Folkman Endostatin: An endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
4. T Sasaki N Fukai K Mann W Gohring BR Olsen R Timpl Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin EMBO J 17 1998 4249 4256
5. T Boehm J Folkman T Browder MS O'Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
6. M Dhanabal R Ramchandran R Volk IE Stillman M Lombardo ML Iruela-Arispe M Simons VP Sukhatme Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma Cancer Res 59 1999 189 197